{"date":"2025-05-12","count":55,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6696-2025-05-12-2025-1uehd3l","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"20:25:07","subject":"代重要子公司Belite Bio, Inc公告受邀參加Benchmark投資銀行舉辦之第五屆醫療線上投資年會(5th Annual Healthcare HouseCall Virtual Investor Conference)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-05-12 20:25，「代重要子公司Belite Bio, Inc公告受邀參加Benchmark投資銀行舉辦之第五屆醫療線上投資年會(5th A」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-05-12-2024-1va4x8d","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"20:24:15","subject":"代重要子公司Belite Bio, Inc公告受邀參加Stifel2025年線上虛擬眼科論壇 2025年會(Stifel 2025Virtual Ophthalmology Forum)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-05-12 20:24，「代重要子公司Belite Bio, Inc公告受邀參加Stifel2025年線上虛擬眼科論壇 2025年會(Stifel」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-05-12-2023-10uhz0l","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"20:23:09","subject":"代重要子公司Belite Bio, Inc公告受邀參加H.C.Wainwright&Co.投資銀行舉辦之第三屆生技交流投資年會(H.C. Wainwright3rd Annual BioConnect Investor Conference)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-05-12 20:23，「代重要子公司Belite Bio, Inc公告受邀參加H.C.Wainwright&Co.投資銀行舉辦之第三屆生技交流投」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-05-12-2022-lndy8l","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"20:22:12","subject":"代重要子公司Belite Bio, Inc公告受邀參加Deutsche Bank投資銀行舉辦之存託憑證線上投資論壇(Depositary Receipts VirtualInvestor Conference)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-05-12 20:22，「代重要子公司Belite Bio, Inc公告受邀參加Deutsche Bank投資銀行舉辦之存託憑證線上投資論壇(De」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-05-12-2016-t3pooq","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"20:16:30","subject":"本公司法人董事代表人改派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-05-12 20:16，「本公司法人董事代表人改派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2025-05-12-1937-1jm43nd","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"19:37:37","subject":"公告本公司取得會計師內部控制專案審查報告","clause":"第25款","fact_date":"2025-05-12","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2025-05-12 19:37，「公告本公司取得會計師內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-05-12-1907-1qytcve","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"19:07:44","subject":"公告本公司董事會通過對關係人捐贈事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-05-12 19:07，「公告本公司董事會通過對關係人捐贈事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-05-12-1905-o02v9u","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-05-12","time":"19:05:07","subject":"本公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款之規定辦理公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-05-12 19:05，「本公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款之規定辦理公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-05-12-1904-1g59lrp","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-05-12","time":"19:04:46","subject":"本公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第一款之規定辦理公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-05-12 19:04，「本公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第一款之規定辦理公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-05-12-1904-1bkm0mx","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-05-12","time":"19:04:19","subject":"公告本公司代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-05-12 19:04，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-05-12-1849-p67uuk","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"18:49:06","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-05-12 18:49，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-05-12-1848-9qofud","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"18:48:26","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-05-12 18:48，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2025-05-12-1847-ijzv89","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"18:47:53","subject":"國璽異體脂肪幹細胞新藥軟實立GXCPC1治療退化性關節炎第三期人體臨床試驗獲衛生福利部同意進行。","clause":"第44款","fact_date":"2025-05-12","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2025-05-12 18:47，「國璽異體脂肪幹細胞新藥軟實立GXCPC1治療退化性關節炎第三期人體臨床試驗獲衛生福利部同意進行。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-05-12-1844-1eg7fsl","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"18:44:06","subject":"公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第3款相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-05-12 18:44，「公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第3款相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-05-12-1843-1eg7fsl","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"18:43:37","subject":"公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第3款相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-05-12 18:43，「公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第3款相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-05-12-1843-1sm5xbj","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"18:43:13","subject":"公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第1款相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-05-12 18:43，「公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第1款相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-05-12-1837-19s0vn5","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"18:37:36","subject":"公告董事會決議通過取得Tract Therapeutics, Inc.100%股權","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-05-12 18:37，「公告董事會決議通過取得Tract Therapeutics, Inc.100%股權」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-05-12-1833-17bfffr","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"18:33:46","subject":"本公司董事會決議通過新設美國子公司及孫公司","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-05-12 18:33，「本公司董事會決議通過新設美國子公司及孫公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2025-05-12-1818-ifuzqn","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"18:18:07","subject":"公告本公司董事會通過114年第一季合併財務報表","clause":"第31款","fact_date":"2025-05-12","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2025-05-12 18:18，「公告本公司董事會通過114年第一季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2025-05-12-1759-1yb2j4q","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"17:59:53","subject":"公告本公司配合資誠聯合會計師事務所內部調整變更會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2025-05-12 17:59，「公告本公司配合資誠聯合會計師事務所內部調整變更會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2025-05-12-1759-9bfmfe","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"17:59:41","subject":"本公司董事會決議第一季不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2025-05-12 17:59，「本公司董事會決議第一季不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2025-05-12-1759-9qofud","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"17:59:24","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2025-05-12 17:59，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2025-05-12-1759-1egfkms","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"17:59:06","subject":"公告本公司董事會通過重要決議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2025-05-12 17:59，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-05-12-1752-1eio3c9","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"17:52:28","subject":"本公司董事會決議辦理私募普通股案(補充公告)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-05-12 17:52，「本公司董事會決議辦理私募普通股案(補充公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-05-12-1742-4e0i34","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"17:42:44","subject":"代子公司共信醫藥科技股份有限公司與馬來西亞F公司簽訂授權及經銷合作備忘錄","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-05-12 17:42，「代子公司共信醫藥科技股份有限公司與馬來西亞F公司簽訂授權及經銷合作備忘錄」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-05-12-1734-17893oj","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"17:34:48","subject":"公告本公司董事會通過114年度第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-05-12 17:34，「公告本公司董事會通過114年度第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2025-05-12-1734-9qofud","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"17:34:34","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"第31款","fact_date":"2025-05-12","cite_as":"公開資訊觀測站重大訊息：合世（1781），2025-05-12 17:34，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-05-12-1732-1okvhlq","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"17:32:21","subject":"公告本公司卡前列素氨丁三醇注射液(Carboprost TromethamineInjection)取得中國國家藥品監督管理局正式核准","clause":"第44款","fact_date":"2025-05-12","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-05-12 17:32，「公告本公司卡前列素氨丁三醇注射液(Carboprost TromethamineInjection)取得中國國家藥品監督」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-05-12-1725-106mkt9","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"17:25:35","subject":"公告本公司法人董事辭任及法人董事指派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-05-12 17:25，「公告本公司法人董事辭任及法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-05-12-1712-12mdixr","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-05-12","time":"17:12:11","subject":"本公司擬與未來新藥股份有限公司簽訂專屬授權合約","clause":"第51款","fact_date":"2025-05-12","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-05-12 17:12，「本公司擬與未來新藥股份有限公司簽訂專屬授權合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-05-12-1710-1ugaxiw","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-05-12","time":"17:10:59","subject":"公告本公司董事會決議通過對關係人捐贈事宜","clause":"第43款","fact_date":"2025-05-12","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-05-12 17:10，「公告本公司董事會決議通過對關係人捐贈事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-05-12-1710-9qofud","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-05-12","time":"17:10:12","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"第31款","fact_date":"2025-05-12","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-05-12 17:10，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-05-12-1708-2yq4po","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"17:08:52","subject":"修訂本公司114年股東常會召集事由案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-05-12 17:08，「修訂本公司114年股東常會召集事由案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-05-12-1707-1lffsmx","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"17:07:41","subject":"本公司董事會決議辦理私募發行普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-05-12 17:07，「本公司董事會決議辦理私募發行普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-05-12-1707-sbjdvg","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"17:07:24","subject":"本公司董事會追認修訂113年度限制員工權利新股發行辦法部分條文","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-05-12 17:07，「本公司董事會追認修訂113年度限制員工權利新股發行辦法部分條文」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-05-12-1707-67dy68","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"17:07:07","subject":"本公司董事會決議113年度限制員工權利新股發行增資基準日(修訂日期)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-05-12 17:07，「本公司董事會決議113年度限制員工權利新股發行增資基準日(修訂日期)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-05-12-1706-1bxh3mj","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"17:06:48","subject":"本公司董事會決議不繼續辦理113年通過辦理發行私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-05-12 17:06，「本公司董事會決議不繼續辦理113年通過辦理發行私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2025-05-12-1659-s364tb","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"16:59:10","subject":"公告本公司訂定除息基準日","clause":"第14款","fact_date":"2025-05-12","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2025-05-12 16:59，「公告本公司訂定除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-05-12-1619-9qofud","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"16:19:02","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-05-12 16:19，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-05-12-1617-1urxqie","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"16:17:06","subject":"公告本公司董事會通過114年第一季財務報告","clause":"第31款","fact_date":"2025-05-12","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-05-12 16:17，「公告本公司董事會通過114年第一季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-05-12-1550-1p0sopl","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"15:50:24","subject":"本公司董事會決議召開民國114年股東常會(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-05-12 15:50，「本公司董事會決議召開民國114年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-05-12-1514-1ebfso9","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"15:14:44","subject":"本公司董事會決議通過將「審計委員會」更名為「審計暨風險管理委員會」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-05-12 15:14，「本公司董事會決議通過將「審計委員會」更名為「審計暨風險管理委員會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-05-12-1513-cqcxin","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"15:13:50","subject":"本公司董事會決議通過將「薪資報酬委員會」更名為「薪資報酬暨提名委員會」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-05-12 15:13，「本公司董事會決議通過將「薪資報酬委員會」更名為「薪資報酬暨提名委員會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-05-12-1512-198290h","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"15:12:54","subject":"本公司董事會決議辦理私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-05-12 15:12，「本公司董事會決議辦理私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-05-12-1512-8hqjh3","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"15:12:11","subject":"本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-05-12 15:12，「本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-05-12-1508-gjco7i","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"15:08:04","subject":"代重要子公司潤雅生技股份有限公司公告法人董事改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-05-12 15:08，「代重要子公司潤雅生技股份有限公司公告法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-05-12-1507-7qunhr","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"15:07:07","subject":"代重要子公司潤雅生技股份有限公司公告法人董事代表人辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-05-12 15:07，「代重要子公司潤雅生技股份有限公司公告法人董事代表人辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-05-12-1506-f4ov2f","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"15:06:00","subject":"本公司研發長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-05-12 15:06，「本公司研發長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-05-12-1505-u4i4ow","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"15:05:19","subject":"本公司董事會決議停止OBI-833專案研發，將資源投入次世代抗體藥物複合體開發","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-05-12 15:05，「本公司董事會決議停止OBI-833專案研發，將資源投入次世代抗體藥物複合體開發」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2025-05-12-1501-1em7eri","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-12","time":"15:01:34","subject":"更正公告本公司董事會決議召開股東常會相關事宜","clause":"第32款","fact_date":"2025-04-02","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2025-05-12 15:01，「更正公告本公司董事會決議召開股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-05-12-1448-17893oj","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-05-12","time":"14:48:13","subject":"公告本公司董事會通過114年度第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-05-12 14:48，「公告本公司董事會通過114年度第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2025-05-12-1438-54swv6","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2025-05-12","time":"14:38:01","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2025-05-12","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2025-05-12 14:38，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2025-05-12-1434-9qofud","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2025-05-12","time":"14:34:20","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"第31款","fact_date":"2025-05-12","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2025-05-12 14:34，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-05-12-1347-1tk3n18","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"13:47:03","subject":"公告本公司董事會通過代理發言人異動追認案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-05-12 13:47，「公告本公司董事會通過代理發言人異動追認案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-05-12-1346-9qofud","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-05-12","time":"13:46:31","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-05-12 13:46，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}